| RS1567817431 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS1567817516 |
RAD51C
|
Health Risk |
Likely pathogenic |
Ovarian neoplasm, Ovarian serous cystadenocarcinoma |
| RS1567817841 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567817865 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567817957 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1567817974 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567817981 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567818032 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567818033 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567818091 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1567818219 |
UNC13D
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1567818236 |
CCDC40
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1567818564 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1567818677 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1567818774 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1567819544 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS1567819753 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1567819834 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS1567819905 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperkalemic periodic paralysis, Congenital myopathy |
| RS1567819954 |
SCN4A
|
Health Risk |
Likely pathogenic |
— |
| RS1567820688 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567820732 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567820765 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567820771 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567822638 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS1567823095 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1567823106 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1567823248 |
KCNJ2
|
Health Risk |
Pathogenic |
Short QT syndrome type 3, Andersen Tawil syndrome |
| RS1567823254 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1567823382 |
BRCA1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS1567825026 |
DGKE
|
Health Risk |
Likely pathogenic |
Immunoglobulin-mediated membranoproliferative glomerulonephritis, DGKE-related disorder |
| RS1567825175 |
GAA
|
Health Risk |
Likely pathogenic |
Elevated circulating creatine kinase concentration, Glycogen storage disease |
| RS1567825391 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1567825858 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567825887 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567826110 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567826158 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS1567826188 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567826603 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567826623 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567826633 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567826819 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567829962 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1567830317 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1567830555 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1567831477 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1567831649 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1567832762 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1567834739 |
SLC4A1
|
Health Risk |
Likely pathogenic |
11 conditions, 11 conditions |
| RS1567834983 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567835161 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567835183 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567835613 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1567835662 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567835775 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1567835781 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1567835847 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567836090 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567838174 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1567838246 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1567838293 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567838311 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567838823 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS1567840389 |
SUZ12
|
Health Risk |
Pathogenic |
— |
| RS1567840448 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1567841596 |
NEUROD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 72 |
| RS1567841799 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567843917 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567843919 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567843930 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567843934 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567843945 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567844041 |
TLK2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS1567844114 |
TLK2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS1567844992 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1567845046 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567845057 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1567845069 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567845116 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567845818 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567845900 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1567845906 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567845935 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567845937 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567845945 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567846600 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567846634 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567846670 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567846698 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567846823 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567847278 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1567847384 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567847398 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567847538 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567847540 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1567847571 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567847621 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567847681 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567847905 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567847962 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |